Overnight home use of artificial pancreas 'feasible and beneficial'

April 23, 2014, University of Cambridge
Credit: Alisha Vargas

(Medical Xpress)—Children with type 1 diabetes have been able to use pioneering artificial pancreas technology, developed at the University of Cambridge, for the first time overnight at home without the supervision of researchers.

The promises to dramatically improve the quality of life for people with type 1 , which typically develops in childhood. All previous artificial pancreas trials, in hospitals and in home environments, have seen researchers strictly monitor patients. The latest trial, funded by JDRF, has shown for the first time that unsupervised use of the artificial pancreas overnight can be safe. The results of the trial are published today in the journal Diabetes Care.

Type 1 diabetes is an autoimmune condition in which the pancreas is unable to produce insulin, a hormone which regulates levels. High levels of glucose can seriously damage the body's organs. People with type 1 diabetes currently rely on multiple insulin injections or pump infusions every day; a child diagnosed at the age of five faces up to 19,000 injections and 50,000 finger prick blood tests by the time they are 18.

Participants in the trial, all aged between 12 and 18, saw improved blood glucose control during the trial, experiencing fewer nights with hypoglycaemic episodes, generally known as 'hypos'. A hypo occurs when the of someone living with type 1 diabetes falls dangerously low. Without proper treatment, it may cause unconsciousness and even death.

A real-time information haul of more than 10,000 UK residents with type 1 diabetes, released to JDRF from the mySugr app, suggests that UK people living with the condition experience an average of ten hypos per week.

Actor Jeremy Irvine, star of the Stephen Spielberg film War Horse, has lived with type 1 diabetes since the age of six. He said: "When the chance came for me to take part in early artificial pancreas trials a few years ago, I jumped at the opportunity. I wanted to play my own very small part in moving the artificial pancreas closer to reality. I'm really excited to hear of this latest progress – the scientists behind it are my heroes."

Dr Roman Hovorka from the University of Cambridge, who is leading the UK effort to develop an effective artificial pancreas, said: "The study is an important stepping stone for the wider use of an artificial pancreas. We have shown that overnight home use is feasible and beneficial – allowing people to live their life more freely.

"The artificial pancreas is expected to transform the treatment of type 1 diabetes and we have proven that this promise holds. The success of this trial means that larger and longer studies are already in the pipeline."

Katharine Barnard, from the Human Development and Health Academic Unit at the University of Southampton, worked with Dr Hovorka on the trial to evaluate psychosocial impact. She said: "Hypoglycaemia – particularly at night – is a common fear among those living with and a major obstacle in achieving optimal blood glucose levels. The findings from this study are positive and are certainly worth investigating further.

"Reassurance, confidence and improved diabetes control are just some of the psychological and physical benefits that patients may witness as artificial pancreas technology continues to develop."

Explore further: The artificial pancreas that keeps tabs on sugar

More information: Roman Hovorka, Daniela Elleri, Hood Thabit, Janet M. Allen, Lalantha Leelarathna, Ranna El-Khairi, Kavita Kumareswaran, Karen Caldwell, Peter Calhoun, Craig Kollman, Helen R. Murphy, Carlo L. Acerini, Malgorzata E. Wilinska, Marianna Nodale, and David B. Dunger. "Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial." Diabetes Care May 2014 37:5 1204-1211; DOI: 10.2337/dc13-2644 1935-5548

Related Stories

The artificial pancreas that keeps tabs on sugar

May 16, 2013
(Medical Xpress)—Development of a sophisticated artificial pancreas holds potential to transform the lives of patients with Type 1 diabetes.

Model predicts blood glucose levels 30 minutes later

March 25, 2014
A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels—plenty ...

Dual-hormone artificial pancreas is a step closer for patients with Type 1 diabetes

January 28, 2013
For patients with type 1 diabetes, a dual-hormone artificial pancreas system (also known as a closed-loop delivery system) improved the control of glucose levels and reduced the risk of hypoglycemia compared with conventional ...

Artificial pancreas may improve overnight control of diabetes in adults

April 15, 2011
Two small randomised trials published in the British Medical Journal today suggest that closed loop insulin delivery (also known as an artificial pancreas) may improve overnight blood glucose control and reduce the risk of ...

Pancreas stem cell discovery may lead to new diabetes treatments

November 14, 2012
(Medical Xpress)—Stem cells in the adult pancreas have been identified that can be turned into insulin producing cells, a finding that means people with type 1 diabetes might one day be able to regenerate their own insulin-producing ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.